Possible risks of transmission of bloodborne infection via acupuncture needles in Guizhou province, Southwest China

Journal of Alternative and Complementary Medicine

Volumn 14, Issue 10, 2008, Pages 1281-1285

  Reynolds, Lucy ^a   McKee, Martin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ACUPUNCTURE; ARTICLE; CHINA; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFECTION RISK; INSTRUMENT STERILIZATION; PREVALENCE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

CHINA; DISPOSABLE EQUIPMENT; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SYRINGES;

EID: 58149265094     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0269     Document Type: Article

References (30)

1. Xia GL, Liu CB, Cao HL, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A,B,C,D, and E virus infections in China, 1992. Internat Haematol Commun 1996;5:62-73.
2. Chen J, Campbell TC, Li J, Peto R, eds. Diet, Lifestyle & Mortality in China. Beijing: People's Publishing House and Ithaca: Cornell University Press, 1990.
3. Jia J-D. Hepatitis B in China: From guideline to practice. Virologia Sinica 2008;23:152-155.
4. Memorandum of Understanding. People's Republic of China, Global Alliance for Vaccination Initiative and the Vaccine Fund, Geneva/Beijing, 2002.
5. Maynard JE, Kane MA, Hadler SC. Global control of hepatitis B through vaccination: Role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989;11:S574-S578.
6. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: A review. Bull World Health Organ 1999;77:789-800.
7. Qu JB, Zhang ZW, Shimbo S, et al. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci 2000;13:243-253.
8. Zhang ZW, Shimbo S, Qu JB, et al. Hepatitis B and C virus infection among adult women in Jilin province, China: An urban-rural comparison in prevalence of infection markers. Southeast Asian J Trop Med Public Health 2000;31:530-536.
9. Fang F, Dong YS, Zhang M. Hepatitis C virus infection in different groups of children in Wuhan area. J Tongji Med Univ 1993;13:239-243.
10. Shimbo S, Zhang ZW, Qu JB, et al. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong province, China. Southeast Asian J Trop Med Public Health 1997;28:500-506.
11. National Sentinel Surveillance/UNAIDS. Country Progress Report, China. Beijing: National Sentinel Surveillance/UNAIDS, 2006.
12. Ernst E, White A. Life-threatening adverse reactions after acupuncture? A systematic review. Pain 1997;71:123-126.
13. Ernst E, Sherman KJ. Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies. J Gastroenterol Hepatol 2003;18:1231-1236.
14. Rampes H, James R. Complications of acupuncture. Acupunct Med 1995;13:26-33.
15. Conn HO. Acupuncture in epidemic HBV hepatitis: In China too? Hepatology 1988;8:1176-1177.
16. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-296.
17. Vittecoq D, Mettetal JF, Rouzioux C, Bach JF, Bouchon JP. Acute HIV infection after acupuncture treatments. N Engl J Med 1989;320:250-251.
18. Castro KG, Lifson AR, White CR, et al. Investigations of AIDS patients with no previously identified risk factors. JAMA 1988;259:1338-1342.
19. Favero MS, Bolyard EA. Microbiologic considerations. Disinfection and sterilization strategies and the potential for airborne transmission of bloodborne pathogens. Surg Clin North Am 1995;75:1071-1089.
20. Centers for Disease Control. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post-exposure Prophylaxis. CDC MMWR Recommendations and Reports, 2001.
21. Krawczynski K, Alter MJ, Robertson BH, Lu L, Spelbring JE, McCaustland KA. Environmental stability of hepatitis C virus (HCV): Viability of dried/stored HCV in chimpanzee infectivity studies [abstract #556]. Hepatology 2003;38:(54):428A.
22. Sattar SA, Tetro J, Springthorpe VS, Giulivi A. Preventing the spread of hepatitis B and C viruses: Where are germicides relevant? Am J Infect Control 2001;29:187-197.
23. Clayton S, Yang H, Guan J, Lin Z, Wang R. Hepatitis B control in China: Knowledge and practices among village doctors. Am J Public Health 1993;83:1685-1688.
24. Li Q, Ou JM, Zeng G. [A cross-sectional survey on injection safety in health facilities in Wulong county, Chongqing city]. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24:176-179.
25. Cao Y, Chen J, Cao JW. Injection practices in health care facilities of Shanghai, China. Geneva: World Health Organization, 2001.
26. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy 2008; [epub ahead of print].
27. Lam TP. Strengths and weaknesses of traditional Chinese medicine and Western medicine in the eyes of some Hong Kong Chinese. J Epidemiol Community Health 2001;55:762-765.
28. Lau WK, Ng MK. Illness behaviour in the Chinese patients: Observations from a rural general practice. Hong Kong Practitioner 1986;8:1989-1896.
29. Callender ME, White YS, Williams R. Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) 1982;284:324-326.
30. Walsh B. Control of infection in acupuncture. Acupunct Med 2001;19:109-111.